Show simple item record

dc.contributor.authorJolly, Amy
dc.contributor.authorNannoni, Stefania
dc.contributor.authorEdwards, Hayley
dc.contributor.authorMorris, Robin
dc.contributor.authorMarkus, Hugh
dc.date.accessioned2022-03-17T00:30:41Z
dc.date.available2022-03-17T00:30:41Z
dc.date.issued2022-05-23
dc.identifier.issn0028-3878
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/335076
dc.description.abstractAbstract Background and Objective CADASIL is the most common monogenic form of stroke and early onset dementia. We determined the prevalence of vascular cognitive impairment (VCI) in a cohort of CADASIL patients, and investigated which factors were associated with VCI risk, including clinical, genetic and MRI parameters. Methods Cognition was assessed in genetically confirmed CADASIL patients (n = 176) and healthy controls (n= 265) (mean(SD) age 50.95(11.35) v 52.37(7.93) years), using the Brief Memory and Executive Test (BMET) and the Montreal Cognitive Assessment (MoCA). VCI was defined according to previously validated cut-offs. We determined the prevalence of VCI and its associations with clinical risk factors, mutation location (EGFr 1-6 versus EGFr 7-34), and MRI markers of small vessel disease. Results VCI was more common in CADASIL than controls; 39.8 v 10.2% on BMET 47.7% v 19.6% of MOCA. CADASIL patients had worse performance across all cognitive domains. History of stroke was associated with VCI on the BMET (OR 2.12, 95% CI [1.05, 4.27] p = 0.04) and on the MoCA (OR 2.55 [1.21, 5.41] p = 0.01), after controlling for age and sex. There was no association of VCI with mutation site. Lacune count was the only MRI parameter independently associated with VCI on the BMET (OR: 1.63, 95% CI [1.10, 2.41], p = 0.014), after controlling for other MRI parameters. These associations persisted after controlling for education in the sensitivity analyses. Conclusions VCI is present in almost half of CADASIL patients with a mean age of 50. Stroke and lacune count on MRI were both independent predictors of VCI on the BMET.
dc.description.sponsorshipThe UK Familial Cerebral Small Vessel Disease is funded by the British Heart Foundation programme grant (RG/4/32218). AJs studentship is supported by the Stroke Association R4VaD grant (RRZA/199). SNs salary is funded by an MRC experimental medicine grant (MR/N026896/1). HSM is supported by an NIHR Senior Investigator award. Recruitment was supported by the NIHR Clinical Research Network. This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) and the Cambridge BHF Centre of Research Excellence [RE/18/1/34212].
dc.publisherLippincott, Williams & Wilkins
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectNeurosciences
dc.subjectAging
dc.subjectClinical Research
dc.subjectNeurodegenerative
dc.subjectBrain Disorders
dc.subjectBehavioral and Social Science
dc.subjectDementia
dc.subjectStroke
dc.subjectAcquired Cognitive Impairment
dc.subjectGenetics
dc.subjectStroke
dc.titlePrevalence, and Predictors, of Vascular Cognitive Impairment in CADASIL
dc.typeArticle
dc.publisher.departmentDepartment of Clinical Neurosciences
dc.date.updated2022-03-16T11:39:52Z
prism.publicationNameNeurology
dc.identifier.doi10.17863/CAM.82516
dcterms.dateAccepted2022-03-11
rioxxterms.versionofrecord10.1212/WNL.0000000000200607
rioxxterms.versionVoR
dc.contributor.orcidJolly, Amy [0000-0003-2669-4998]
dc.contributor.orcidMarkus, Hugh [0000-0002-9794-5996]
dc.identifier.eissn1526-632X
rioxxterms.typeJournal Article/Review
cam.issuedOnline2022-05-23
cam.orpheus.successWed Jun 08 08:57:05 BST 2022 - Embargo updated
cam.orpheus.counter5
cam.depositDate2022-03-16
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International